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Volume 56, Number 2 Abstracts 579endoleak. This endovascular aortic strategy is particularly appealing for
those patients presenting with symptomatic or ruptured aortic aneurysms
until reliable off-the-shelf solutions become widely available.
Table. Operative details
Variable Mean (range)
Aneurysm diameter, mm 65 (55-91)
Proximal neck length, mm 4.8 (2-11)
Manufacture time, minutes 59 (31-78)
Procedure time, minutes 166 (96-378)
Fluoroscopy time, minutes 45 (19.7-164)
Total contrast, mL 65 (30-120)
Estimated blood loss, mL 200 (20-1000)
Length of stay, days 5.8 (1.3-23.7)
Endoleaks After Endovascular Repair of Ruptured Abdominal Aortic
Aneurysm: Should They Be Treated?
Nam T. Tran, Brandon Tyler Garland, Elina Quiroga, Benjamin Starnes, MD,
and Thomas Hatsukami. Department of Surgery, University of Washington,
Seattle, Wash
Objective: The management of ruptured abdominal aortic aneurysm
has undergone significant changes within the last decade, with endovascular
repair (rEVAR) now the preferred operative approach. We hypothesized that
some endoleaks after rEVAR can be managed expectantly, whereas others
require urgent intervention to due to ongoing hemorrhage.
Methods: In an Investigational Review Board-approved study, all
patients admitted with the diagnosis of rAAA from July 2007 to December
2011 were entered into a prospectively maintained database. Patients with
rEVAR and computed tomography angiography (CTA) performed within
the first 30 days of repair were included in the analysis. Images were analyzed
by attending radiologists for presence and type of endoleak as well as
aneurysm size. Relevant patient data, such as hemodynamic status, hemat-
ocrit level, transfusion requirement, hospital length of stay, and outcome,
were analyzed.
Results: Sixty-three patients (79% men) were identified who had
undergone rEVAR, and in 34, CTA was performed 30 days of the
procedure. The mean age was 74.5 years. Four type I endoleaks, one type III
endoleak, and seven type II endoleaks were identified. The overall endoleak
rate was 35.2% (12 of 34). Two of four type I endoleaks required urgent
reintervention due to hemodynamic instability. The patient with type III
endoleak was stable, but follow-up imaging demonstrated a retroperitoneal
hematoma and the sac diameter had increased in size and thus underwent
reintervention. No type II endoleaks required further intervention. At 2
years, all endoleaks except two of seven type II have resolved.
Conclusions: The rate of endoleak after rEVAR is higher than that
reported for elective endovascular repair. Type II endoleaks resolved spon-
taneously over time and should be managed conservatively. Conversely, type
I and III endoleaks can lead to continual rapid hemorrhage and should
undergo intervention. CTA should be performed on all rEVAR patients
before discharge.
Determinants of Abdominal Aortic Aneurysm Sac Enlargement After
Endovascular Aneurysm Repair with a Long-Term Follow-Up to 15
Years
Carlos E. Donayre, MD, Faidzal Othman, MD, George E. Kopchok, BS,
Ali Khoynezhad, MD, and Rodney A. White, MD. Department of Surgery/
Division Vascular Surgery, Harbor–University of California-Los Angeles
Medical Center, Torrance, Calif
Objective: Studies have documented abdominal aortic aneurysm
(AAA) enlargement in up to 41% of patients 5 years after endovascular repair
(EVAR). Noting limitations of patient selection and length of follow-up, the
current analysis was undertaken to assess AAA enlargement in an unselected
patient cohort with follow-up for up to 15 years after repair.
Methods: Between 1996 and 2011, 586 consecutive patients (mean
age, 73.9  9.0 years; 89.5% male; mean AAA diameter, 58  12 mm)
underwent EVAR. Of these, 196 (59%) were part of an investigational device
exemption (IDE) study and 137 (41%) received a commercially available
device (CAD). Centralized three-dimensional imaging computed tomogra-
phy surveillance (M2S, West Lebanon, NH) was available in 333 patients
(56%) over a median follow-up of 36 months (range, 1-180 months).
Multivariate and univariate Cox regression models were used to assess time
to AAA enlargement (5 mm vs baseline), estimating the hazard ratio (HR)
and 95% confidence intervals (CI) for AAA enlargement compared with
baseline.
t
eResults: The proportion of patients who developed AAA enlargement
t 1, 3, 5, and 8 years after repair was 4.5%, 12.5%, 21.6%, and 31.7%,
espectively (Fig). Mean time to enlargement was 42  38 months. Multi-
ariable analysis identified age (HR 1.045; 95% CI, 1.011-1.081; P  .01)
nd common iliac diameter (HR 1.047; 95% CI, 1.016-1.078; P .002) as
redictors of enlargement. At 15 years, enlargement occurred in 57 patients
17.1%), with secondary interventions required in 25 (endovascular in 22
nd open conversion in three). Only one rupture occurred in this group.
utcome in the IDE and CAD groups did not differ with respect to AAA
nlargement or the frequency of secondary interventions.
Conclusion: This single-center, unselected patient cohort with long-
erm CT follow-up documented AAA enlargement in a smaller proportion
f patients than has been reported in other series. Certain baseline patient
haracteristics can be identified that are associated with AAA enlargement,
ut the risk of enlargement did not differ in IDE vs CAD groups.
ase-Specific Endovascular Aneurysm Repair Simulation: A Pilot
omparison of Simulated Aneurysm Repair with Actual Live Cases
enita Chandra, MD,2 Robert Gowing, MD,1 Amy Peruzarro, BS,2 and
ason T. Lee, MD2. 1Vascular Surgery, McMaster University Medical
enter, Hamilton, Ontario, Canada; and 2Stanford University Medical
enter, Stanford, Calif
Objective: Patient-specific endovascular aneurysm repair (EVAR) sim-
lation has the potential to allow the operative team, particularly trainees, to
ehearse an entire case on the patient’s actual anatomy before performing the
ctual procedure. To better understand how closely outcomes of live cases
easured up to simulated ones, we analyzed the operative metrics of EVAR
imulations compared with previously performed cases.
Methods: Four completed actual EVAR cases were selected at random
o be “simulated.” Digital Imaging and Communications in Medicine data
rom preoperative computed tomography images were rendered into the
ROcedure Rehearsal Studio system, and the simulated cases were per-
ormed by a similarly experienced operative team of faculty and fellows. In
oth the actual and simulated cases, interval times to critical steps were
ecorded along with device components, repeat interventions, contrast
mounts, and fluoroscopy times.
Results: Compared with the actual live cases, the metrics simulated
ases were similar, including mean total operating room time (69 min),
uoroscopy time (22.8 min), and contrast usage (83.5 mL). Deployment of
he contralateral limb was used as a surrogate for cannulation complexity,
hich showed these times were significantly faster in the simulation group
completed at 39 vs 50.5 minutes). Total number of device components
sed was similar; however, the main body and iliac limb diameters were
requently different, with iliac limb lengths equivalent. The simulated cases
ad a higher incidence of type Ia endoleak that required additional proximal
allooning (no cuffs) compared with the actual cases.
Conclusions: Rehearsal of actual EVAR cases is feasible using current
imulation technology, with standard operative metrics replicated accurately
n the simulation group. Certain steps were easier on the simulator, indicat-
ng room for improvement in simulation technology, but overall procedural
onduct of the cases was similar to live case timelines. The potential educa-
Fig.ional benefits and increased procedural efficiency to both trainees and
xperienced EVAR users requires further investigation.
